Gsk (GLAXF) Shares Outstanding (Weighted Average) (2009 - 2026)

Gsk's Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $1818692.7 billion for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 7.04% year-over-year to $1818692.7 billion; the TTM figure through Mar 2026 stood at $1818692.7 billion (up 7.04% YoY), while the FY2025 annual figure was $1778670.4 billion, up 103224016.37% from the prior year.
• Shares Outstanding (Weighted Average) was $1818692.7 billion for Q1 2026 at Gsk, up from $1794394.2 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $4915520.5 billion in Q1 2023 to a low of $1.7 billion in Q4 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $1617416.3 billion across 5 years, with a median of $1707491.1 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) slumped 65.6% in 2024, then soared 103712487.53% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $4.7 billion in 2022, then increased by 6.5% to $5.0 billion in 2023, then plunged by 65.6% to $1.7 billion in 2024, then jumped by 103712487.53% to $1794394.2 billion in 2025, then increased by 1.35% to $1818692.7 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $1818692.7 billion (Q1 2026), $1794394.2 billion (Q4 2025), and $1820289.5 billion (Q3 2025), per Business Quant data.